The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease
Open accessAbstract
Patients with Alzheimer's disease can present with different clinical phenotypes. Individuals with late-onset Alzheimer's disease (>65 years) typically present with medial temporal lobe neurodegeneration and predominantly amnestic symptomatology, while patients with early-onset Alzheimer's disease (<65 years) exhibit greater neocortical involvement associated with a clinical presentation including dyspraxia, executive dysfunction, or visuospatial impairment. We recruited 20 patients with early-onset Alzheimer's disease, 21 with late-onset Alzheimer's disease, three with prodromal early-onset Alzheimer's disease and 13 with prodromal late-onset Alzheimer's disease, as well as 30 cognitively healthy elderly controls, that had undergone 18F-AV-1451 tau positron emission tomography and structural magnetic resonance imaging to explore whether early- and late-onset Alzheimer's disease exhibit differential regional tau pathology and atrophy patterns. Strong associations of lower age at symptom onset with higher 18F-AV-1451 uptake were observed in several neocortical regions, while higher age did not yield positive associations in neither patient group. Comparing patients with early-onset Alzheimer's disease with controls resulted in significantly higher 18F-AV-1451 retention throughout the neocortex, while comparing healthy controls with late-onset Alzheimer's disease patients yielded a distinct pattern of higher 18F-AV-1451 retention, predominantly confined to temporal lobe regions. When compared against each other, the early-onset Alzheimer's disease group exhibited greater uptake than the late-onset group in prefrontal and premotor, as well as in inferior parietal cortex. These preliminary findings indicate that age may constitute an important contributor to Alzheimer's disease heterogeneity highlighting the potential of tau positron emission tomography to capture phenotypic variation across patients with Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated tau PET binding in both medial temporal lobe structures and the neocortex is strongly associated with positive amyloid PET scans and with clinical impairment across the normal aging to dementia clinical spectrum [82,130–141].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [137]
In the citing paper
“Recent tau PET studies with [18F]flortaucipir showed that EOAD had greater tau burden in the neocortex compared to LOAD patients (Cho et al., 2017; Schöll et al., 2017).”
From Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease (2021) · cites this paper as Schöll et al., 2017
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
Automatically Parcellating the Human Cerebral Cortex
Fischl, B. R. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg087 · Cited by 4,208
Cognitive reserve in ageing and Alzheimer's disease
Stern, Y. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70191-6 · Cited by 3,557
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., Hampel, H., Jagust, W. J., Johnson, K. A., Knopman, D. S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002923 · Cited by 1,864
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Self-citationPET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
Self-citation
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–177 of 177
Distinct fiber-specific white matter reductions pattern in early- and late-onset Alzheimer’s disease
Luo, X., Wang, S., Jiaerken, Y., Li, K., Zeng, Q., Hong, H., Guan⁴, X., Guo, T., Wang, C., Zhang, R., et al. (2021) · Aging · doi:10.18632/aging.202702 · Cited by 19
Lv, X., Cheng, Z., Wang, Q., Gao, F., Dai, L., Du, C., Liu, C., Xie, Q., Shen, Y., & Shi, J. (2023) · 中国科学通报：英文版 · doi:10.1016/j.scib.2023.10.019 · Cited by 17
Mehta, R. I., Keith, C. M., Teixeira, C. V. L., Worhunsky, P. D., Phelps, H. E., Ward, M., Miller, M. D., Navia, R. O., Pockl, S., Rajabalee, N., et al. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae475 · Cited by 15
Wang, J., Wang, M., Ren, S., Huang, L., He, K., Li, J., Hua, F., Guan, Y., Guo, Q., Huang, Q., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221166 · Cited by 15
Angelopoulou, E., Bougea, A. M., Hatzimanolis, A., Scarmeas, N., & Papageorgiou, S. G. (2024) · Cells · doi:10.3390/cells13131164 · Cited by 15
Lagarde, J., Maiti, P., Schonhaut, D. R., Blazhenets, G., Zhang, J., Eloyan, A., Thangarajah, M., Taurone, A., Allen, I. E., Soleimani‐Meigooni, D. N., et al. (2025) · Annals of Neurology · doi:10.1002/ana.27233 · Cited by 14
Dai, Y., Qiu, D., Wang, Y., Dong, S., & Wang, H. (2018) · International Journal of Pattern Recognition and Artificial Intelligence · doi:10.1142/s0218001419570015 · Cited by 14
Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
O’Connor, A., Cash, D. M., Poole, T., Markiewicz, P. J., Fraser, M. R., Malone, I. B., Jiao, J., Weston, P. S. J., Flores, S. E., Hornbeck, R. C., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01234-5 · Cited by 15
Self-citationAD molecular: Imaging tau aggregates with positron emissions tomography
Betthauser, T. J. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.007 · Cited by 14
Corriveau‐Lecavalier, N., Machulda, M. M., Botha, H., Graff‐Radford, J., Knopman, D. S., Lowe, V. J., Fields, J. A., Stricker, N. H., Boeve, B. F., Jack, C. R., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11025-x · Cited by 16
Lee, W. J., Yoon, C. W., Kim, S.-W., Jeong, H. J., Seo, S., Na, D. L., Noh, Y., & Seong, J.-K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.606600 · Cited by 12
Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease
Bastiani, M. A. D., Bellaver, B., Carello‐Collar, G., Zimmermann, M., Kunach, P., Lima‐Filho, R. A. S., Forner, S., Martini, A. C., Pascoal, T. A., Lourenco, M. V., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108671 · Cited by 13
Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PET
Hong, J., Kang, S. K., Alberts, I., Lu, J., Sznitman, R., Lee, J. S., Rominger, A., Choi, H., Shi, K., & Initiative, T. A. D. N. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05662-z · Cited by 13
Boon, B. D. C., Labuzan, S. A., Peng, Z., Matchett, B. J., Kouri, N., Hinkle, K. M., Lachner, C., Ross, O. A., Ertekin‐Taner, N., Carter, R. E., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207685 · Cited by 11
Tau biomarkers for neurodegenerative diseases: Current state and perspectives
Vacchi, E., Ruíz‐Barrio, I., & Melli, G. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.107772 · Cited by 11
Genetically identical twin-pair difference models support the amyloid cascade hypothesis
Coomans, E. M., Tomassen, J., Ossenkoppele, R., Tijms, B. M., Lorenzini, L., ten Kate, M., Collij, L. E., Heeman, F., Rikken, R. M., van der Landen, S. M., et al. (2023) · Brain · doi:10.1093/brain/awad077 · Cited by 11
Self-citationAlterations of Structural Network Efficiency in Early-Onset and Late-Onset Alzheimer’s Disease
Heo, S., Yoon, C. W., Kim, S.-Y., Kim, W., Na, D. L., & Noh, Y. (2024) · Journal of Clinical Neurology · doi:10.3988/jcn.2023.0092 · Cited by 10
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease
Iaccarino, L., Llibre‐Guerra, J. J., McDade, E., Edwards, L., Gordon, B. A., Benzinger, T. L. S., Hassenstab, J. J., Kramer, J. H., Li, Y., Miller, B. L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae159 · Cited by 11
Katsumi, Y., Touroutoglou, A., Brickhouse, M. J., Eloyan, A., Eckbo, R., Zaitsev, A., Joie, R. L., Lagarde, J., Schonhaut, D. R., Thangarajah, M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14489 · Cited by 12
Martersteck, A., Sridhar, J., Coventry, C., Weıntraub, S., Mesulam, M. M., & Rogalski, E. J. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12445 · Cited by 11
Characterizing Early-Onset Alzheimer Disease Using Multiprobe PET/MRI
Xu, X., Ruan, W., Liu, F., Liu, Q., Gai, Y., Su, Y., Liang, Z., Sun, X., & Lan, X. (2023) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004663 · Cited by 9
Zhang, W., Xu, S., Yu, H., Li, X., Jin, Z., Li, Y., & He, Z. (2021) · Annals of Nuclear Medicine · doi:10.1007/s12149-020-01566-4 · Cited by 8
Gaudreault, R., Hervé, V., van de Ven, T. G. M., Mousseau, N., & Ramassamy, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201549 · Cited by 8
Olivieri, P., Hamelin, L., Lagarde, J., Hahn‐Barma, V., Guichart-Gomez, E., Roué-Jagot, C., & Sarazin, M. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00829-0 · Cited by 8
Frontzkowski, L. K., Gnörich, J. S., Groß, M., Dehsarvi, A., Roemer, S. N., Palleis, C., Katzdobler, S., Dewenter, A., Steward, A., Biel, D., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07396-8 · Cited by 11
Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes
Boccalini, C., Mathoux, G., Hristovska, I., Ribaldi, F., Peretti, D. E., Arnone, A., Scheffler, M., Frisoni, G. B., Hansson, O., Vogel, J. W., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213950 · Cited by 7
Self-citationImaging Clinical Subtypes and Associated Brain Networks in Alzheimer’s Disease
Herholz, K. (2022) · Brain Sciences · doi:10.3390/brainsci12020146 · Cited by 8
Sex‐specific topological structure associated with dementia via latent space estimation
Wang, S., Wang, Y., Xu, F. H., Tian, X., Fredericks, C. A., Shen, L., Zhao, Y., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14266 · Cited by 6
Amyloid-β and tau deposition in traumatic brain injury: a study of Vietnam War veterans
de Bruin, H., Groot, C., Kamps, S., Vijverberg, E. G. B., Steward, A., Dehsarvi, A., Pijnenburg, Y. A. L., Ossenkoppele, R., & Franzmeier, N. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf009 · Cited by 5
Self-citationGeneralizable MRI normative modelling to detect age-inappropriate neurodegeneration
Parker, T. D., Bethlehem, R. A. I., Seidlitz, J., White, S. R., David, M., Kolanko, M., Bernstock, J. D., Dorfschmidt, L., Bourke, N., de Taurines, A. F. L. G., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01872-x · Cited by 7
Self-citationAdvances in fluorescent probe design and imaging applications for Alzheimer's disease biomarker
Li, Y., Liu, H., Yin, C., & Huo, F. (2025) · Dyes and Pigments · doi:10.1016/j.dyepig.2025.113411 · Cited by 5
Perron, J., & Ko, J. H. (2022) · Applied Sciences · doi:10.3390/app122211463 · Cited by 5
Huang, Y.-Y., Chiu, M., Yen, R., Tsai, C.-L., Hsieh, H.-Y., Chiu, C., Wu, C., Hsin, L., Tzen, K., Cheng, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217384 · Cited by 5
Li, Y., Yao, Z., Yu, Y., Fu, Y., Zou, Y., Hu, B., & Initiative, A. D. N. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00208 · Cited by 5
Calibration of Biophysical Models for tau-Protein Spreading in Alzheimer's Disease from PET-MRIPreprint
Scheufele, K., Subramanian, S., & Biros, G. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.01236 · Cited by 5
Liu, M., Chang, H., Huang, S., Huang, C., Hsu, S., Lin, K., Ho, T., Huang, K., Cheng, C., & Chang, C. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111343 · Cited by 4
He, F., Shi, W.-J., Liu, W., Fan, J.-X., He, Z., Zhang, Y., Xiao, J., Ruan, W., Gai, Y., Zhang, H., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251334316 · Cited by 4
Kim, H., Jang, J. H., Ham, H.-G., Choo, S. H., Park, J.-H., Kang, S. H., Hwangbo, S., Jang, H., Na, D. L., Seo, S. W., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210650 · Cited by 4
PET and SPECT Imaging of Neurodegenerative Diseases
Drzezga, A. E., Bischof, G. N., Giehl, K., & van Eimeren, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00085-5 · Cited by 4
Distinct tau PET dynamics in early versus late age-of-onset Alzheimer’s disease
Chiotis, K., Blazhenets, G., Soleimani‐Meigooni, D. N., Aisen, P. S. S., Amuiri, A. N., Atri, A., Beckett, L. A., Brickhouse, M. J., Clark, D. G., Dage, J. L., et al. (2026) · Science Translational Medicine · doi:10.64898/2026.01.25.26344738 · Cited by 4
Na, H. K., Shin, J., Kim, S.-W., Seo, S., Kim, W., Kang, J. M., Lee, S., Cho, J., Byun, J., Okamura, N., et al. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0308 · Cited by 3
Li, Y., Wang, X., Ge, Q., Graeber, M. B., Yan, S., Li, J., Li, S., Gu, W., Hu, S., Benzinger, T. L. S., et al. (2025) · EJNMMI Physics · doi:10.1186/s40658-025-00761-4 · Cited by 3
Tau PET imaging evidence in patients with cognitive impairment: preparing for clinical use
Noirot, C., Mainta, I., Mendes, A., Andryszak, P., Visvaratnam, H., Unschuld, P. G., Frisoni, G. B., & Garibotto, V. (2018) · Clinical and Translational Imaging · doi:10.1007/s40336-018-0297-4 · Cited by 3
Sun, N., Mormino, E. C., Chen, J., Sabuncu, M. R., Yeo, B. T. T., & Initiative, A. D. N. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462143 · Cited by 3
Kang, J. M., Shin, J., Kim, W., Seo, S., Seo, H., Lee, S.-Y., Park, K. H., Na, D. L., Okamura, N., Seong, J.-K., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230339 · Cited by 2
Wang, X., Ye, T., Dai, B., Zhang, J., Zhou, W., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251406131 · Cited by 2
Research progress in neuroimaging of sporadic early-onset Alzheimer’s disease
Zhang, X., & Yang, C. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1788814 · Cited by 2
Ehrlich, D., Dunzinger, A., Malsiner‐Walli, G., Grün, B., Topakian, R., Hodolič, M., Kainz, E., & Pichler, R. (2021) · Radiology and Oncology · doi:10.2478/raon-2021-0051 · Cited by 3
Early Onset Alzheimer's Disease
Hyer, L. A. (2018) · MOJ Gerontology & Geriatrics · doi:10.15406/mojgg.2018.03.00086 · Cited by 2
Cho, J., Yoon, C. W., Shin, J., Seo, H., Kim, W., Na, H. K., Byun, J., Lockhart, S. N., Kim, C., Seong, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71402-6 · Cited by 2
Tau-PET Bildgebung der Demenzerkrankungen
Bischof, G. N. (2022) · Angewandte Nuklearmedizin · doi:10.1055/a-1712-6020 · Cited by 2
Palmqvist, S., & Eshaghi, A. (2020) · Neurology · doi:10.1212/wnl.0000000000011272 · Cited by 2
Self-citationPoli, M., Bonomi, C. G., Donna, M. G. D., Barberis, I., Ginevra, E., Nuccetelli, M., Bernardini, S., Centonze, D., Martorana, A., & Motta, C. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13833-x · Cited by 1
Zapater‐Fajarí, M., Bucci, M., Chiotis, K., Almkvist, O., Wall, A. E., Eriksson, J., Antoni, G., Pola, I., Tan, K., Traichel, W., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-08015-w · Cited by 1
Shir, D., Corriveau‐Lecavalier, N., Jones, D. T., Ramanan, V. K., Lachner, C., Knopman, D. S., Petersen, R. C., Josephs, K. A., Day, G. S., Graff‐Radford, J., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218347 · Cited by 1
Diferencias neuropsicológicas en la enfermedad de Alzheimer en función de la edad de presentación
Echeveste, B., Tellechea, P., Montoya, G., Espinoza‐Vinces, C., Fernández-Montero, A., & Riverol, M. (2023) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2023.101433 · Cited by 1
Hong, H., Chen, Y., Liu, W., Luo, X., Zhang, M., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12585 · Cited by 1
In Situ Labeling of Pathogenic Tau Using Photo-Affinity Chemical Probes
Nie, P., Wu, Y., Robinson, J. L., Mekala, S., Lee, V. M. ‐., & Li, Y. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00073 · Cited by 1
Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
Frings, L., Hellwig, S., Brumberg, J., Rau, A., Mix, M. D., Blazhenets, G., Urbach, H., & Meyer, P. T. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70142 · Cited by 1
Role of Liver in Alzheimer’s Disease
(2020) · ARC Journal of Neuroscience · doi:10.20431/2456-057x.0403003 · Cited by 1
PET Biomarkers for Tau Pathology
Leuzy, A., Heurling, K., & Schöll, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-27779-6_13
Self-citationIn Early-Onset Alzheimer's Disease, Evidence of More Brain Pathology and a Faster Course
Talan, J. (2020) · Neurology Today · doi:10.1097/01.nt.0000717988.22407.4b
McKeever, P. M. (2018) · TSpace (University of Toronto)
Diagnosi clinicolaboratoristica della malattia di Alzheimer
Lagarde, J., Olivieri, P., Bottlaender, M., & Sarazin, M. (2021) · EMC - Neurologia · doi:10.1016/s1634-7072(21)45320-1 · Cited by 1
Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PETPreprint
Hong, J., Kang, S. K., Alberts, I., Lu, J., Sznitman, R., Lee, J. S., Rominger, A., Choi, H., & Shi, K. (2021) · Research Square · doi:10.21203/rs.3.rs-880967/v1
Tau Imaging in Neurodegenerative Dementia
Ponisio, M. R., Iranpour, P., & Benzinger, T. L. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_12
PET Biomarkers for Tau Pathology
Leuzy, A., Heurling, K., & Schöll, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-54196-4_13
Self-citationA century of Alzheimer's disease: Merging neuropathology with in vivo biomarkers
Harrison, T. M., & Jagust, W. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-822240-9.00013-2
Vavsari, V. F., Golmohammadi, F., & Balalaie, S. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837677139-00411
A Case Report Exploring Early-Onset Alzheimer’s Disease With No Known Family History
Bains, J., & Ogunjobi, O. (2025) · Cureus · doi:10.7759/cureus.90576
Lee, W. J., Cho, H., Baek, M. S., Kim, H.-K., Lee, J. H., Ryu, Y. H., Lyoo, C. H., & Seong, J.-K. (2022) · Figshare · doi:10.6084/m9.figshare.20887205
Simrén, J., Brum, W. S., Ashton, N. J., Benedet, A. L., Karikari, T. K., Kvartsberg, H., Sjons, E., Lussier, F. Z., Chamoun, M., Stevenson, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22605773
Mundada, N. S., Rojas, J. C., Vandevrede, L., Thijssen, E. H., Iaccarino, L., Okoye, O., Shankar, R. P., Soleimani-Meigooni, D. N., Lago, A. L., Miller, B. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24186176
O’Connor, A., Cash, D. M., Poole, T., Markiewicz, P. J., Fraser, M. R., Malone, I. B., Jiao, J., Weston, P. S. J., Flores, S. E., Hornbeck, R. C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23208001
Self-citationHemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Dunlop, S. R., Lincoln, S., Peng, Z., Graff‐Radford, N. R., Lachner, C., Day, G. S., Tranovich, J. F., Reichard, R. R., Dickson, D. W., Petersen, R. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.01.735558
Keith, C. M., Haut, M. W., Worhunsky, P. D., Teixeira, C. V. L., Mehta, R. I., Malone, J. E., Phelps, H. E., Ward, M., Miller, M. D., Pockl, S., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261469183
Metadata
- Authors
- Schöll, M., Ossenkoppele, R., Strandberg, O., Palmqvist, S., study, T. S. B., Jögi, J., Ohlsson, T., Smith, R., & Hansson, O.
- Affiliations
- Lund University (SE)
- Amsterdam Neuroscience (NL)
- Skåne University Hospital (SE)
- Corresponding author
- Schöll, Michael
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-07-16
- Volume
- 140
- Issue
- 9
- Pages
- 2286-2294
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2751819353
- Cited by
- 180
- References
- 28
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 13 · 2023: 24 · 2022: 17 · 2021: 30 · 2020: 29 · 2019: 23 · 2018: 16 · 2017: 1
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Research Council
- Swedish Research Council
- Swedish Brain Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- Alzheimer's disease, early-onset Alzheimer's disease, late-onset Alzheimer's disease, 18F-AV-1451, tau PET, age at symptom onset, prodromal Alzheimer's disease, temporal lobe atrophy, prefrontal cortex, inferior parietal cortex, disease heterogeneity, clinical phenotype
- MeSH terms
- Aged, Aging, Alzheimer Disease, Atrophy, Carbolines, Cerebral Cortex, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Case-Control Studies, tau Proteins, Age of Onset, Tauopathies, Positron-Emission Tomography, Neuroimaging, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
